JP2023552846A5 - - Google Patents

Info

Publication number
JP2023552846A5
JP2023552846A5 JP2023535046A JP2023535046A JP2023552846A5 JP 2023552846 A5 JP2023552846 A5 JP 2023552846A5 JP 2023535046 A JP2023535046 A JP 2023535046A JP 2023535046 A JP2023535046 A JP 2023535046A JP 2023552846 A5 JP2023552846 A5 JP 2023552846A5
Authority
JP
Japan
Prior art keywords
sequence
seq
antibody
antigen
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2023535046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023552846A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/084520 external-priority patent/WO2022122704A1/en
Publication of JP2023552846A publication Critical patent/JP2023552846A/ja
Publication of JP2023552846A5 publication Critical patent/JP2023552846A5/ja
Ceased legal-status Critical Current

Links

JP2023535046A 2020-12-08 2021-12-07 メタニューモウイルスのf-タンパク質に結合する抗体およびその使用 Ceased JP2023552846A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EPPCT/EP2020/085014 2020-12-08
EP2020085014 2020-12-08
EPPCT/EP2020/085747 2020-12-11
EP2020085747 2020-12-11
PCT/EP2021/084520 WO2022122704A1 (en) 2020-12-08 2021-12-07 Antibodies binding to f-protein of metapneumovirus and uses thereof

Publications (2)

Publication Number Publication Date
JP2023552846A JP2023552846A (ja) 2023-12-19
JP2023552846A5 true JP2023552846A5 (cg-RX-API-DMAC7.html) 2024-11-22

Family

ID=78844890

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023535046A Ceased JP2023552846A (ja) 2020-12-08 2021-12-07 メタニューモウイルスのf-タンパク質に結合する抗体およびその使用

Country Status (4)

Country Link
US (1) US20240034772A1 (cg-RX-API-DMAC7.html)
EP (1) EP4259654A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023552846A (cg-RX-API-DMAC7.html)
WO (1) WO2022122704A1 (cg-RX-API-DMAC7.html)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076677A2 (en) 2003-02-26 2004-09-10 Institute For Research In Biomedicine Monoclonal antibody production by ebv transformation of b cells
US7700097B2 (en) 2003-06-27 2010-04-20 Biogen Idec Ma Inc. Purification and preferential synthesis of binding molecules
JP4976376B2 (ja) * 2005-04-08 2012-07-18 メディミューン,エルエルシー 哺乳動物メタニューモウイルスに対する抗体
JP2010505876A (ja) * 2006-10-04 2010-02-25 ザ スクリプス リサーチ インスティテュート ヒトメタニューモウイルスを中和するヒト抗体
MX2009012343A (es) 2007-05-14 2010-02-10 Biogen Idec Inc Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello.
ES2525346T3 (es) 2008-10-22 2014-12-22 Institute For Research In Biomedicine Métodos para producir anticuerpos a partir de células plasmáticas
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
US10420834B2 (en) 2014-12-24 2019-09-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant metapneumovirus F proteins and their use
US11312761B2 (en) * 2016-10-21 2022-04-26 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
CN118359709A (zh) * 2019-05-21 2024-07-19 佐治亚大学研究基金会有限公司 结合人类偏肺病毒融合蛋白的抗体及其用途

Similar Documents

Publication Publication Date Title
Scheid et al. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
JP7328479B2 (ja) 重症熱性血小板減少症候群ウイルスの外膜糖タンパク質に結合する抗体及びその用途
JP7209464B2 (ja) ヒトインターロイキン-2に対する免疫刺激性モノクローナル抗体
US20200347130A1 (en) CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof
JP6421371B2 (ja) トランスポーターに対する抗体およびその用途
JP2012518425A5 (cg-RX-API-DMAC7.html)
JP2005528914A5 (cg-RX-API-DMAC7.html)
AU2015322141A1 (en) High affinity and aggregatively stable antibodies on the basis of variable domains Vl and a derivative VHH
JP2020515277A5 (cg-RX-API-DMAC7.html)
JP7304288B2 (ja) ジストログリカンおよびラミニン2に対する特異性を有する多特異性結合性分子
JP2017507131A5 (cg-RX-API-DMAC7.html)
JP2025507595A5 (cg-RX-API-DMAC7.html)
WO2021212785A1 (zh) 一种全人源单克隆抗体及其应用
JPWO2022224997A5 (cg-RX-API-DMAC7.html)
CN114591434A (zh) 抗Siglec15抗体及其制备方法和用途
JP2022528387A (ja) アビド結合多重特異性抗体を作製する方法
JP2021515597A5 (cg-RX-API-DMAC7.html)
JP2024535124A5 (cg-RX-API-DMAC7.html)
KR20240031229A (ko) 알파-시누클레인병증 치료용 항체
WO2021238854A1 (zh) 抗SARS-CoV-2刺突蛋白的单克隆抗体及其制备方法和用途
TWI867354B (zh) 新穎Nav1.7單株抗體
WO2020205504A1 (en) Common light chains and methods of use
CN115337396A (zh) 一种全人源单克隆抗体组合及其应用
KR102845060B1 (ko) 니파바이러스 및 헨드라바이러스에 특이적인 단클론항체 및 이의 용도
CN115433273B (zh) 具有中和活性的抗新冠病毒兔重组单克隆抗体及应用